Participant satisfaction in a preclinical Alzheimer's disease trial

Abstract

Background: There is growing interest in preclinical Alzheimer’s disease (AD) trials, as they offer an opportunity to test treatments at early stages of the disease. Yet, there is a lack of data regarding participant feedback on enrollment in these trials.

The paper